DGX — Quest Diagnostics Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapSuper Stock

Annual income statement for Quest Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	10,788	9,883	9,252	9,872	11,035
Cost of Revenue
Gross Profit	4,278	3,465	3,066	3,273	3,677
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	8,407	8,455	7,990	8,526	9,479
Operating Profit	2,381	1,428	1,262	1,346	1,556
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,599	1,235	1,130	1,175	1,318
Provision for Income Taxes
Net Income After Taxes	2,002	971	882	902	1,004
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	1,995	946	854	871	992
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,988	942	850	866	988
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	16.2	8.6	7.9	8.08	9.38
Dividends per Share